AILERON THERAPEUTICS INC (ALRN) Stock Balance Sheet
NASDAQ:ALRN - Nasdaq - US00887A2042 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 17.65M | 17.31M | 5.19M | 3.60M | 7.05M | |||
| Marketable Securities | N/A | 0.00 | 16.05M | 42.33M | 6.76M | |||
| Other Current Assets | 1.03M | 953.00K | 640.00K | 2.25M | 2.52M | |||
| Total Current Assets | 18.68M | 18.27M | 21.87M | 48.18M | 16.33M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.00K | 19.00K | 110.00K | 280.00K | 20.00K | |||
| Goodwill | 6.33M | 6.33M | N/A | N/A | N/A | |||
| Intangibles | 79.20M | 79.20M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 2.00K | 2.19M | 20.00K | 20.00K | 0.00 | |||
| Total Non-Current Assets | 85.53M | 87.74M | 140.00K | 300.00K | 10.00K | |||
| TOTAL ASSETS | 104.22M | 106.01M | 22.01M | 48.48M | 16.34M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 170.00K | |||
| Accrued Expenses | 4.58M | 3.19M | 1.66M | 3.30M | 2.20M | |||
| Accounts Payable | 1.08M | 1.19M | 1.72M | 1.21M | 1.60M | |||
| Total Current Liabilities | 5.66M | 4.38M | 3.38M | 4.51M | 3.96M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 220.00K | |||
| Deferred Taxes/Income | 3.33M | 3.33M | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | 70.00K | 0.00 | |||
| Total Non-Current Liabilities | 3.33M | 3.33M | 0.00 | 70.00K | 220.00K | |||
| TOTAL LIABILITIES | 8.98M | 7.71M | 3.38M | 4.58M | 4.18M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -310.42M | -288.52M | -272.79M | -245.46M | -219.29M | |||
| Additional Paid In Capital | 360.56M | 295.38M | 291.37M | 289.28M | 231.41M | |||
| Common Shares | 45.11M | 91.50M | 90.00K | 90.00K | 40.00K | |||
| Other Shareholders' Equity | -26.00K | -63.00K | -50.00K | -10.00K | 0.00 | |||
| Shares Outstanding | 21.67M | 4.89M | 4.54M | 4.53M | 2.19M | |||
| Tangible Book Value per Share | -1.63 | -16.10 | 4.10 | 9.69 | 5.55 | |||
| Total Shareholders' Equity | 95.23M | 98.30M | 18.62M | 43.90M | 12.16M | |||
| TOTAL LIABILITIES AND EQUITY | 104.22M | 106.01M | 22.01M | 48.48M | 16.34M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.02 | |||
| Current Ratio | 3.30 | 4.17 | 6.47 | 10.68 | 4.12 | |||
| Return On Assets (ROA) | -28.06% | -14.84% | -124.17% | -53.96% | -129.50% | |||
| Return On Equity (ROE) | -30.71% | -16.00% | -146.78% | -59.59% | -174.01% | |||
All data in USD , ROIC based on taxRate of 0.21